Advances in Cancer Therapy

Kalorama Information
February 1, 2001
394 Pages - SKU: KLI25
Malignant Melanoma: KOL Insight
10/17/2014 | published by: FirstWord
Introduction Malignant Melanoma: PD-1 inhibitors revolutionise treatment is a comprehensive report with insights from 12 leading US and European KOLs offering their latest views on current and late-stage pipeline products, why and  |  read more...
USD 6,495
Opportunity in Biotechnology Industry in India - 2014
10/13/2014 | published by: Feedback Business Consulting Services Pvt. Ltd.
Opportunity in Biotechnology Industry in India - 2014 This report provides an insight into the Opportunity in Biotechnology Industry current scenario, structure and practices in India. In depth market scenario includes; Current market size estimates Market size by players  |  read more...
USD 6,000
Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014’, provides an overview of the Hormone-Sensitive Prostate Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Global Proton Therapy Market 2014-2018
10/15/2014 | published by: TechNavio - Infiniti Research Ltd.
Global Proton Therapy Market 2014-2018 About Proton Therapy Proton therapy is a type of particle therapy which is used to treat cancer patients by means of proton beams irradiation. The main advantage of proton therapy is that  |  read more...
USD 2,500
Papillary Thyroid Cancer - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Papillary Thyroid Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Papillary Thyroid Cancer - Pipeline Review, H2 2014’, provides an overview of the Papillary Thyroid Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
miRNA Research and Diagnostics Markets
9/4/2014 | published by: Kalorama Information
miRNA Research and Diagnostics Markets This report considers the diagnostic promise of non-coding RNA molecules, with a particular focus on the microRNAs.  miRNAs (MicroRNAs) are short, single stranded RNAs  |  read more...
USD 2,995
Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to 2019
9/23/2014 | published by: MarketsandMarkets
Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to 2019 The global ablation technologies market is estimated to grow  |  read more...
USD 4,650
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014’, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL)’s therapeutic pipeline. This report  |  read more...
USD 2,000
Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2014’, provides an overview of the Multiple Myeloma (Kahler's Disease)’s therapeutic pipeline. This report provides comprehensive information  |  read more...
USD 2,000
Renal Cell Carcinoma - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Renal Cell Carcinoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 350  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!